Skip to content

Mirror therapy for neglecting the paralyzed body part in Stroke

Task-based and Magnified Mirror Therapy for Unilateral Spatial Neglect among Post-Stroke Subjects: A Randomized Controlled Trial - T-MAGUSN

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053184
Enrollment
86
Registered
2023-05-29
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G819- Hemiplegia, unspecified

Interventions

Intervention1: Task-based and MAGnified Mirror Therapy for Unilateral Spatial Neglect (T-MAGUSN): The experimental intervention will comprise of the following components - 1.Task-based upper limb mir

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. First episode of unilateral stroke (as defined by WHO)2. Ischemic or hemorrhagic stroke 3. 1 to 36 months after the stroke onset 4. Hemiparesis (right or left) (as assessed by Fugl-Meyer assessment38 upper extremity subsection: 0 to 66) 5. USN (defined as an asymmetry between the Letter cancellation task omissions in the contralesional (left) and ipsilesional (right) visual field of at least 2 letters) 6. Normal visual abilities (with or without glasses) 7. Muscle tone: Modified Ashworth scale 1 to 2

Exclusion criteria

Exclusion criteria: 1.Receptive communication or other language disorder (which could interfere with the assessment and treatment process) 2. Severe other cognitive impairment (MMSE = 17) 3. Homonymous Hemianopia. 4. Contractures and deformities of hand / finger 5. Use of hand splinting or orthosis 6. Complex regional pain syndrome 7. Concomitant medical illness 8. Cardiovascular instability: resting systolic blood pressure >200mmHg and resting diastolic blood pressure >100 mmHg 9. Pregnancy 10. Renal infection or failure 11. Severe depression (Beck depression inventory > 30)

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Assessment Timepoint: Baseline, At 8 week (Post intervention), At 12 week (Follow-up)

Secondary

MeasureTime frame
1.Catherine Bergego Scale 2.Berg Balance Scale 3.Functionl Ambulation Category 4. Modified Rankin ScaleTimepoint: Baseline, 8- Weeks Postintervention, 12-Weeks Follow-up

Countries

India

Contacts

Public ContactDr Kamal Narayan Arya

PDUNIPPD

kamalnarya@yahoo.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026